Pharmacologic induction of innate immune signaling directly drives homologous recombination deficiency.

Saved in:
Bibliographic Details
Title: Pharmacologic induction of innate immune signaling directly drives homologous recombination deficiency.
Authors: McLaughlin LJ; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD 21201.; Program in Oncology, Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD 21201., Stojanovic L; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD 21201.; Program in Oncology, Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD 21201., Kogan AA; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD 21201.; Program in Oncology, Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD 21201., Rutherford JL; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD 21201.; Program in Oncology, Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD 21201., Choi EY; Program in Oncology, Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD 21201.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201., Yen RC; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231., Xia L; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231., Zou Y; Program in Oncology, Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD 21201.; Department of Pathology, University of Maryland School of Medicine, Baltimore, MD 21201., Lapidus RG; Program in Oncology, Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD 21201.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201., Baylin SB; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231; sbaylin@jhmi.edu mtopper1@jhmi.edu frassool@som.umaryland.edu., Topper MJ; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231; sbaylin@jhmi.edu mtopper1@jhmi.edu frassool@som.umaryland.edu., Rassool FV; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD 21201; sbaylin@jhmi.edu mtopper1@jhmi.edu frassool@som.umaryland.edu.; Program in Oncology, Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD 21201.
Source: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2020 Jul 28; Vol. 117 (30), pp. 17785-17795. Date of Electronic Publication: 2020 Jul 10.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1091-6490
DOI:10.1073/pnas.2003499117